Patients across Wisconsin rely on innovative drug therapies for their health and well being. But, the rising cost of prescription drugs is threatening patient access and squeezing healthcare budgets. It’s also prompted finger pointing on who is to blame, preventing consensus on how to move forward. On April 30, 2024, Wisconsin Health News will host a virtual panel of experts to examine what more can be done to control costs and preserve access.
Panelists:
- Kevin Mead, National Director of Market Access Strategic Accounts, Novo Nordisk
- Sean Stephenson, Director of State Affairs, PCMA
- Nathan Houdek, Commissioner of Insurance, State of Wisconsin
- Dr. Mark Huth, CEO, Group Health Cooperative of South Central Wisconsin